We speculate that CD25+ or CD25+FOXP3+CD45RA− stromal cell count reflects the stromal responses to antitumoral immunity, and that their ratios to CD8+ cell count may be equivalent to the strength of antitumoral immune status particularly involved in tumor chemosensitivity. Here, FOXP3 is linked to neoplasm.